Created at 4:57 a.m. Aug, 22, 2024
Author: tarkleson
Related Note: 1543504724150 1
Rationale for change

Just having 2 here in the hint makes it sound like you need 2 in combination

Text Text
Extra
- There is a lot of strong evidence for SGLT-2 inhibitor effectiveness for weight loss (& reduced heart failure mortality and protection from diabetic nephropathy)

- Examples of GLP-1 agonists are semaglutide, liraglutide, and exenatide

- Metformin induces weight loss (or stabilization)

- DPP-4 inhibitors (sitagliptin and saxagliptin) are weight neutral

- Sulfonylureas, thiazolidinediones, and insulin are associated with weight gain
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy

Sketchy 2


Watch Diabetes Management
Sketchy Extra


Watch Metformin, Thiazolidinediones, Pramlintide, SGLT2 Inhibitors
Picmonic
Empty field
Pixorize


Review SGLT2 Inhibitors (Gliflozins)


Review GLP-1 Analogs
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources

One by one
Empty field
#AK_Step2_v12::!Shelf::IM #AK_Step1_v12::#B&B::08_Endocrinology::03_Pancreas::04_Treatment_of_Diabetes::Extra #AK_Step2_v12::!Shelf::FM #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step2_v12::#AMBOSS::8E0Ox3 #AK_Step2_v12::#UWorld::COMLEX::103504 !AK_UpdateTags::^temporary::ImageFix::18::done !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Family-Medicine::1-OME::7 #AK_Step3_v12::#UWorld::5061 #AK_Step2_v12::#UWorld::Step::2192 #PANCE::EOR::IM #AK_Step2_v12::#UWorld::Step::16507 #AK_Step2_v12::#Resources_by_rotation::FM::ome::endo::outpatient_dm #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment #AK_Step2_v12::Original_decks::Dorian::fam::ome::endo::outpatient_dm #AK_Step3_v12::#UWorld::107729 #AK_Step2_v12::#Subjects::Endocrinology::06_Pancreas::Diabetes::*Management_REDO #PANCE::ENDO::diabetes AnkiHub_ImageReady::Extra #AK_Step2_v12::#UWorld::COMLEX::28010 #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::02_GLP-1_Analogs #AK_Step2_v12::Original_decks::Dorian::im::uw::endocrine #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#AMBOSS::02aeTP #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Endocrinology::Outpatient_Type_2_Diabetes_Mellitus #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::07_GLP-1_Analogs #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_zanki #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_dorian AnkiHub_ImageReady::Text #AK_Step2_v12::#Resources_by_rotation::IM::ome::endo::outpatient_dm #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #AK_Step2_v12::#AMBOSS::OBaIaM #AK_Step2_v12::#OME::01_Medicine::07_Endocrinology::06_Outpatient_Type_2_Diabetes #AK_Step2_v12::Original_decks::Dorian::im::ome::endo::outpatient_dm #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::02_Metformin,_Thiazolidinediones,_Pramlintide,_SGLT2_Inhibitors #AK_Step2_v12::#UWorld::Step::6921 #AK_Step1_v12::#AMBOSS #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Endocrine,_Diabetes,_&_Metabolism